Special Issue "Electroporation-Based Cancer Treatment. Selected Papers from the 4th World Congress on Electroporation"

A special issue of Cancers (ISSN 2072-6694).

Deadline for manuscript submissions: 31 December 2022.

Special Issue Editor

Prof. Dr. Julie Gehl
E-Mail Website
Guest Editor
1. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark
2. Center for Experimental Drug and Gene Electrotransfer (C*EDGE), Department of Clinical Oncology and Palliative Care, Zealand University Hospital, Sygehusvej 10, 4000 Roskilde, Denmark
Interests: Cancer; Oncology; Electroporation; Electrochemotherapy; Calcium electroporation; Exercise Oncology

Special Issue Information

Dear Colleagues,

Electric fields can cause cell permeabilization (electroporation), and this is increasingly being used in cancer therapy. Cell permeabilization may be transient (reversible), allowing for the passage of molecules, e.g.: chemotherapy (electrochemotherapy); ions; nucleotides, such as DNA; RNA. With higher field strengths, irreversible electroporation (IRE) can be achieved, leading to cancer cell death through the loss of cell integrity. The field is developing with different types of electric pulses as well as novel equipment, expanding indications.

This Special Issue brings together papers on basic and clinical research from presentations at the 4th world congress on Electroporation, held in Copenhagen in 2021. Electroporation based cancer therapy is being used for the treatment of cancer of different histologies and for tumors located, for example, in the skin, head and neck area, gastrointestinal tract, as well as in tumors in the liver. Basic research is developing our understanding of underlying mechanisms and expanding indications for treatment. This Special Issue bridges basic and clinical research in electroporation based cancer therapy, highlighting the developmental frontier within the field.

Prof. Dr. Julie Gehl
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • electroporation
  • cancer
  • electrochemotherapy
  • calcium electroporation
  • irreversible electroporation (IRE)

Published Papers

This special issue is now open for submission.
Back to TopTop